Medical Health & Life Science Research News

New report examines the North American to contribute over 41% to the global needle-free diabetes management market by 2025

New report examines the North American to contribute over 41% to the global needle-free diabetes management market by 2025

The factors driving the growth of the market include increasing awareness regarding the safety issues associated with needles and high prevalence of diabetes globally.

- Advertisement -
- Market Research Pro -

The study suggests that the global needle-free diabetes management market is likely to grow from $3,830.6 million in 2016 to $16.8 billion by 2025. With the explosive growth of needle-free treatment devices and the increasing awareness regarding the safety issues associated with needles, the needle-free diabetes management market is gaining traction.

The growing need for development of safe needle-free diagnostic device has fueled the demand for continuous blood glucose monitoring across all regions worldwide.

Browse the Report Summary at: www.psmarketresearch.com/market-an…management-market image   The study suggests that the global needle-free diabetes management market is likely to grow from $3,830.6 million in 2016 to $16.8 billion by 2025.

- Advertisement -
- Market Research Pro -
With the explosive growth of needle-free treatment devices and the increasing awareness regarding the safety issues associated with needles, the needle-free diabetes management market is gaining traction.

The growing need for development of safe needle-free diagnostic device has fueled the demand for continuous blood glucose monitoring across all regions worldwide.  

Request to Sample: www.psmarketresearch.com/market-an…ket/report-sample

Geographically, North America has been the largest market for needle-free diabetes management devices, with an estimated 41.5% contribution to the global market in 2016. Globally, The U.S. had been the largest country for needle-free diabetes management devices in 2016 and it is expected to continue being the largest market during the forecast period.

In 2016, Japan is the major market in Asia-Pacific, whereas in Europe, Germany generates highest revenue in this market.   Report Enquiry at: www.psmarketresearch.com/send-enqu…management-market   The adoption of needle-free diabetes management in the emerging economies is expected to provide huge growth potential for the market, during the forthcoming years.

The growth will be driven by the increasing healthcare awareness and increasing healthcare spending. The countries such as China and India have a huge market potential as the healthcare industry is witnessing significant growth in these countries.  

The research states that the manufacturers in the needle-free diabetes management market are focusing continually on workflow enhancements and improving diabetes management and device performance. Currently, the healthcare cost is outpacing the government expenditure on healthcare.

The development of technologically advanced diabetes management devices has become necessary to ensure increased healthcare efficiency and productivity. Some of the key players in the global market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.

News From

P&S Market ResearchP&S Market Research
Category: Market Research Publishers and RetailersCompany profile: PS Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our pub ...